Valuation: Torrent Pharmaceuticals Limited

Market Cap 1,73100Cr 1.83TCr 1.63TCr 1.51TCr 1.37TCr 2.57TCr 2.61TCr 18TCr 7.1TCr 91TCr 6.85TCr 6.71TCr 2,88900Cr P/E 2027 *
67.2x
P/E 2028 * 48.8x
Enterprise Value 1,85300Cr 1.96TCr 1.74TCr 1.61TCr 1.46TCr 2.75TCr 2.79TCr 19TCr 7.6TCr 97TCr 7.34TCr 7.18TCr 3,09300Cr EV / Sales 2027 *
9.35x
EV / Sales 2028 * 8.17x
Free-Float
36.82%
Yield 2027 *
0.72%
Yield 2028 * 0.84%
1 day-0.21%
1 week-1.83%
Current month-5.23%
1 month-5.29%
3 months-9.05%
6 months+8.65%
Current year+18.44%
1 week 4,529.35
Extreme 4529.35
4,656.85
1 month 4,529.35
Extreme 4529.35
5,010
Current year 3,724.1
Extreme 3724.1
5,249.95
1 year 3,532.85
Extreme 3532.85
5,249.95
3 years 1,822.8
Extreme 1822.8
5,249.95
5 years 1,242.5
Extreme 1242.5
5,249.95
10 years 571.75
Extreme 571.75
5,249.95
Manager TitleAgeSince
Chief Executive Officer 34 01/08/2025
Director of Finance/CFO - 01/09/2018
Chief Tech/Sci/R&D Officer - 01/02/2026
Director TitleAgeSince
Chairman 62 30/07/2014
Director/Board Member 59 07/03/2019
Director/Board Member 59 29/07/2022
Date Insider Type Main position Quantity % Market Cap. Importance
29/11/24 Buy

Chief Operating Officer

9,30,144 0.2748%
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-1.83%+27.45%+140.89% 1.83TCr
+3.49%+10.04%+58.68%+119.56% 1,10600Cr
+2.19%+4.32%+33.88%+69.52% 61TCr
+2.26%+5.37%+24.57%+97.69% 50TCr
+2.58%+8.37%+38.71%+63.14% 37TCr
+3.25%+4.45%+71.80%+44.44% 35TCr
+1.85%+6.04%+21.47%+49.17% 29TCr
+1.76%+6.07%+0.43%+20.98% 26TCr
+3.29%+6.32%+44.71%+57.43% 23TCr
+2.25%+5.81%+27.13%+101.17% 19TCr
Average +1.82%+3.50%+34.88%+76.40% 39.18TCr
Weighted average by Cap. +1.43%+4.63%+40.76%+80.86%

Financials

2027 *2028 *
Net sales 20TCr 209.22Cr 186.23Cr 172.6Cr 156.4Cr 293.93Cr 298.85Cr 2.07TCr 813.58Cr 10TCr 784.79Cr 768.52Cr 33TCr 22TCr 235.65Cr 209.75Cr 194.4Cr 176.15Cr 331.06Cr 336.6Cr 2.33TCr 916.34Cr 12TCr 883.92Cr 865.58Cr 37TCr
Net income 2.47TCr 26Cr 23Cr 21Cr 19Cr 37Cr 37Cr 257.63Cr 101.21Cr 1.29TCr 98Cr 96Cr 4.12TCr 3.42TCr 36Cr 32Cr 30Cr 27Cr 51Cr 52Cr 357.44Cr 140.42Cr 1.79TCr 135.45Cr 132.64Cr 5.71TCr
Net Debt 12TCr 128.63Cr 114.5Cr 106.12Cr 96Cr 180.72Cr 183.74Cr 1.27TCr 500.21Cr 6.38TCr 482.51Cr 472.5Cr 20TCr 9.31TCr 98Cr 88Cr 81Cr 73Cr 138.11Cr 140.42Cr 973.08Cr 382.27Cr 4.87TCr 368.74Cr 361.1Cr 16TCr
Projected Income Statement - Annual - Torrent Pharmaceuticals Limited
Logo Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company focuses on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), women healthcare (WHC), Vitamins Minerals & Nutrients (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynecology, oncology and anti-infective segments. Its brands include Ahaglow, Shelcal, Tedibar, and Unienzyme. Its tedibar brands include Tedibar bathing bar, Tedibar Atogla, Tedibar Spoo and Tedibar B4 Nappi. Its Shelcal includes Shelcal 500, Shelcal Pro Gummies, Kids Gummies, and Shelcal Total. The Company's manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.
Employees
18,258
Date Price Change Volume
19/26/19 ₹4,550.30 -0.21% 4,437
16/26/16 ₹4,560.00 -1.00% 2,898
15/26/15 ₹4,605.95 +0.26% 5,893
14/26/14 ₹4,594.00 -0.88% 1,04,340
13/26/13 ₹4,635.00 -0.94% 1,776
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Torrent Pharmaceuticals Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
4,550.30INR
Average target price
5,481.14INR
Spread / Average Target
+20.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Torrent Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. 500420 Stock